Cholestatic Pruritus clinical trials at UC Davis
1 research study open to eligible people
A Study of Experimental CR845 (Difelikefalin) for Primary Biliary Cholangitis (PBC) and Pruritus (skin itching)
open to eligible people ages 18-80
This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of twice-daily (BID) oral CR845 1.0 mg in patients with PBC with moderate-to-severe pruritus. The study includes a 16-week Treatment Period.
San Francisco, California and other locations